KUVATRIS THERAPEUTICS, INC.
CIK 0001811623
Revenue (TTM)
$0
Q3 Jan 2026
Net Income (TTM)
−$12.62M
−23.6% YoY
Q3 Jan 2026
EPS Diluted (TTM)
−$6.19
+61.8% YoY
Q3 Jan 2026
Gross Margin
—
Q3 Jan 2026
Operating Margin
—
Q3 Jan 2026
Net Margin
—
Q3 Jan 2026
Free Cash Flow (TTM)
—
Q3 Jan 2026
Cash
$3.99M
Q3 Jan 2026
Total Debt
—
Q3 Jan 2026
Shares Outstanding
126.26M sh
Q3 Jan 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.